Osteoclastogenesis Assay
Osteoclastogenesis Assay - Related Videos
04:27
Effect of the Anti C-fms Antibody on Osteoclastogenesis in Mouse Bone Marrow Cells In Vitro
0 Views •
2025
In this video, we demonstrate the effect of different anti-c-fms antibody concentrations on osteoclastogenesis, which is the process of osteoclast formation from osteoclast progenitors.
09:51
Methods for Analyzing the Impacts of Natural Uranium on In Vitro Osteoclastogenesis
0 Views •
Cited by 5 •
2018
Uranium is known to affect bone metabolism. Here, we present a protocol aimed at investigating the effect of natural uranium exposure on the viability, the differentiation, and the function of osteoclasts, the cells in charge of bone resorption.
06:00
Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines
0 Views •
Cited by 6 •
2017
This protocol describes development of an in vitro human preclinical model of osteoclastogenesis from peripheral blood monocytes cultured with breast cancer cell lines to mimic the cancer cell-osteoclast interaction. The model could be used to further our understanding of bone metastasis formation and improve therapeutic options.
08:12
The TUNEL Assay
0 Views •
2023
One of the hallmarks of apoptosis is the nuclear DNA fragmentation by nucleases. These enzymes are activated by caspases, the family of proteins that execute the cell death program. TUNEL assay is a method that takes advantage of this feature to detect apoptotic cells. In this assay, an enzyme called terminal deoxynucleotidyl transferase catalyzes the addition of dUTP nucleotides to the free 3’ ends of fragmented DNA. By using dUTPs that are labeled with chemical tags that can produce...
09:12
Aortic Ring Assay
0 Views •
Cited by 42 •
2009
Angiogenesis, the sprouting of blood vessels from pre-existing vasculature, is associated with both natural and pathological processes. Here we demonstrate an aortic ring assay that allows angiogenic potentiators and inhibitors to be directly added to aortic rings in culture. Sprouting and neovessel outgrowth can be determined by inspecting the aortic rings over a period of 6-12 days.
FAQs
Macrophage colony-stimulating factor (M-CSF) and receptor activator of nuclear factor kappa-B ligand (RANKL) contribute at different stages of the culture response. M-CSF supports precursor-cell survival, while RANKL promotes fusion and osteoclast-specific gene expression. Applying these signals together therefore creates conditions for development of the osteoclast phenotype in vitro.
These readouts provide complementary evidence of differentiation. Tartrate-resistant acid phosphatase staining indicates acquisition of an osteoclast-associated cellular feature, whereas multinucleation reflects fusion of precursor-derived cells into the characteristic cell form. Considering both observations helps assess whether cultured monocyte or macrophage precursors have developed features associated with osteoclast formation.
Experimental exposure to inflammatory mediators or pathogens can be evaluated by examining whether osteoclast formation changes in cultured precursor cells. The resulting pattern of tartrate-resistant acid phosphatase staining and multinucleation helps reveal effects on differentiation, while connecting immune or infectious stimuli with processes relevant to bone loss. This supports investigation of immune-driven skeletal damage in vitro.
First, monocyte or macrophage precursors are maintained in culture. The cells are then exposed to M-CSF and RANKL to support survival, fusion, and osteoclast-specific gene expression. After the differentiation period, cultures are evaluated using tartrate-resistant acid phosphatase staining and by assessing multinucleation. These observations indicate the extent of osteoclast formation.
It can show whether a pathogen is associated with altered formation of osteoclasts in cultured precursor cells. Because osteoclasts are responsible for bone resorption, changes detected through staining and multinucleation provide an in vitro indication that infection-related signals may influence processes linked to bone loss. The assay therefore connects infection research with cellular mechanisms of skeletal damage.
Candidate drugs can be evaluated for their ability to regulate osteoclast formation in cultures stimulated with M-CSF and RANKL. Researchers can then examine changes in tartrate-resistant acid phosphatase staining and multinucleation as indicators of altered differentiation. This application supports assessment of interventions intended to modify immune-driven bone loss or inflammatory effects on the skeleton.